A problematic pattern of tobacco or nicotine use leading to significant impairment or distress, the most widely used addictive substance worldwide.
Medically reviewed by
Dr. Mihaela G.
Tobacco Use Disorder describes a problematic pattern of using cigarettes, other smoked tobacco, or nicotine products, leading to clinically significant impairment or distress. Despite being legal and culturally normalized in most places, tobacco is, by several important measures, among the most addictive substances covered in this entire manual; a notably high proportion of people who use it regularly go on to develop genuine dependence, considerably higher than the corresponding rate for alcohol or cannabis.
What makes tobacco distinct from most other substances in this chapter is the mismatch between its legal, normalized status and its addictive potential and health impact. It remains the leading cause of preventable death worldwide, yet because it doesn’t produce the dramatic intoxication or acute impairment associated with alcohol or many other substances, its addictive grip and cumulative harm are sometimes underestimated, both by users themselves and, historically, by society more broadly.
A genuinely encouraging feature of this otherwise sobering picture is that tobacco use disorder responds well to treatment, and unlike several substances in this chapter, there are multiple well-evidenced medications specifically for supporting cessation, making this one of the more treatable conditions here despite its high addictive potential.
Impaired control over use
Using tobacco more or for longer than intended, persistent desire or unsuccessful efforts to cut down or quit, and significant time spent using or obtaining tobacco.
Social and functional impairment
Continued use despite interpersonal or occupational problems, giving up or reducing important activities because of the need to use, and recurrent use in physically hazardous situations.
Risky use and craving
Continued use despite knowledge of physical harm, particularly given how clearly tobacco’s health risks are understood, and strong, persistent craving.
Tolerance
Needing markedly increased amounts to achieve the desired effect, or markedly diminished effect with continued use of the same amount.
Withdrawal
A well-characterized withdrawal syndrome when use is reduced or stopped, frequently a significant, practical barrier to successful quitting and a major driver of continued use for many people.
⋅ Strong, frequent craving to use tobacco
⋅ Anxiety connected to anticipated unavailability of tobacco
⋅ Irritability when use is delayed or interrupted
⋅ Distress connected to repeated, unsuccessful attempts to quit
⋅ Persistent preoccupation with obtaining or using tobacco
⋅ Difficulty concentrating, particularly during withdrawal
⋅ Minimization of the extent of use or its health consequences
⋅ Automatic, habitual patterns of use connected to specific routines or triggers
⋅ Tolerance, requiring more tobacco for the same effect
⋅ Withdrawal symptoms including irritability, restlessness, and increased appetite
⋅ Respiratory and cardiovascular symptoms connected to sustained use
⋅ Physical signs connected to specific products used, such as oral health effects
⋅ Using tobacco more frequently or in greater quantity than intended
⋅ Continued use despite clear health, social, or financial consequences
⋅ Structuring daily routines around opportunities to use
⋅ Repeated, unsuccessful attempts to quit or cut down
Roughly 20% of adults globally use tobacco regularly, and tobacco shows one of the highest rates of progression from regular use to dependence among substances covered in this manual, a notably higher proportion than seen with alcohol or cannabis.
Risk factors include early age of first use, a family history of tobacco use or other substance use disorders, co-occurring mental health conditions, particularly depression and anxiety, and social environments where tobacco use is more normalized or accessible.
Comorbidity with depression, anxiety, and other substance use disorders, particularly alcohol, is substantial, and the relationship with mental health conditions is frequently bidirectional, with many people using tobacco to manage mood or anxiety symptoms, even as sustained use itself can worsen these same conditions over time.
Tobacco Use Disorder develops through the interaction of neurobiological, genetic, and environmental factors, with nicotine’s specific action on the brain’s reward system playing a particularly potent role.
Rapid nicotine delivery to the brain, especially via smoking, produces an extremely fast onset of effect, reaching the brain within seconds, contributing significantly to its high addictive potential by creating an unusually tight, rapid link between the behavior (using tobacco) and the rewarding effect.
Nicotinic receptor adaptation with sustained use leads to increased receptor density and altered sensitivity, directly underlying both tolerance and the withdrawal syndrome that follows cessation.
Genetic factors contribute substantially to individual vulnerability, with twin studies indicating one of the higher heritability estimates among substance use disorders, alongside specific genetic variation affecting nicotine metabolism that influences both initial use patterns and dependence risk.
Behavioral and environmental conditioning plays a particularly significant role for tobacco specifically; the habitual, repetitive nature of use, often tied to specific routines, times of day, or emotional states, creates powerful behavioral associations that can persist and trigger craving long after the pharmacological effects of any single use have worn off.
Tobacco Use Disorder is diagnosed based on a problematic pattern of use leading to clinically significant impairment or distress, evidenced by at least two of eleven criteria within a 12-month period, mirroring the structure used across substance use disorders: using more or longer than intended, persistent desire or unsuccessful efforts to cut down, significant time spent obtaining/using, craving, recurrent failure to fulfill role obligations, continued use despite interpersonal problems, giving up important activities, recurrent hazardous use, continued use despite physical/psychological problems, tolerance, and withdrawal. Severity is specified based on the number of criteria met.
Differential diagnosis for this condition is relatively more straightforward than for several other substances in this chapter, since occasional, non-dependent tobacco use is less common than with substances like alcohol or cannabis; most regular tobacco use that continues over time meets criteria for at least a mild use disorder, given nicotine’s high addictive potential.
Tobacco Use Disorder has a particularly strong treatment evidence base, combining effective medication options with well-established behavioral approaches.
Nicotine replacement therapy
Patches, gum, lozenges, and other nicotine replacement products reduce withdrawal severity by providing nicotine through a safer delivery method than smoking, supporting gradual reduction and cessation.
Varenicline and bupropion
Varenicline, which partially activates nicotine receptors while blocking the more intense reward from continued smoking, and bupropion, an antidepressant also approved for smoking cessation, are both well-evidenced, effective medication options, often more effective than nicotine replacement alone.
Behavioral counseling
Brief or more intensive behavioral counseling, addressing triggers, building coping strategies, and supporting motivation, meaningfully improves quit rates, particularly when combined with medication.
Combination treatment
Combining medication with behavioral counseling produces the best outcomes for most people, considerably better than either approach used alone, and is generally the recommended standard for anyone seeking to quit.
Addressing comorbid mental health conditions
Given how frequently tobacco use co-occurs with depression and anxiety, attention to these conditions, sometimes including consideration of how cessation might temporarily affect mood, is an important part of comprehensive, well-supported treatment.
Combine medication with behavioral support for the best chance of success. Varenicline, bupropion, or nicotine replacement, alongside counseling, significantly outperforms trying to quit through willpower alone.
Expect withdrawal symptoms and have a plan for managing them. Irritability, increased appetite, and difficulty concentrating are common in the first couple of weeks, and knowing this in advance helps you persist through the discomfort.
Identify your specific triggers and routines connected to use. Given how strongly habitual patterns contribute to this disorder, having a concrete plan for high-risk moments, specific times, situations, or emotional states, supports more successful, sustained change.
Don’t be discouraged by previous unsuccessful attempts. Most people who successfully quit do so only after multiple attempts, and each attempt, even an unsuccessful one, can provide useful information for the next.
Address any underlying anxiety or depression directly. Given how often tobacco use is connected to managing these symptoms, treating them directly supports more sustainable cessation.
The prognosis for Tobacco Use Disorder with appropriate, combined medication and behavioral treatment is genuinely good, and this combination significantly improves quit rates compared to unassisted attempts.
Without treatment, the disorder tends to persist for many years, often decades, with accumulating health consequences, though even long-term users who successfully quit see significant health benefits beginning relatively soon after cessation and continuing over time.
Multiple quit attempts are the norm, not the exception, and persistence, particularly when combined with effective treatment, considerably improves the likelihood of eventual, sustained success.
Comorbid depression or anxiety, when present, generally benefits from concurrent, coordinated attention alongside cessation treatment.
Seek treatment, ideally combining medication and behavioral support, if you’re using tobacco regularly and want to quit, given how significantly this combination improves your chances of success compared to attempting it alone.
Seek support specifically if previous quit attempts haven’t been successful. This is extremely common, and working with a provider on a more structured, supported approach can meaningfully improve your odds on a subsequent attempt.
Seek evaluation for any underlying depression or anxiety that tobacco use might be connected to managing, since addressing this directly often supports more sustainable cessation.
Someone in your life might be quietly looking for this. Share it:
These conditions share overlapping symptoms and are often misdiagnosed.
Nicotine reaches the brain extremely quickly, within seconds when smoked, creating an unusually tight, rapid connection between the behavior and the rewarding effect. A notably high proportion of people who use tobacco regularly go on to develop genuine dependence, a considerably higher rate than seen with substances like alcohol or cannabis. Its legal, culturally normalized status doesn’t reflect a lower addictive potential; if anything, this normalization has historically led to its addictive grip and health impact being underestimated.
Nicotine replacement therapy, including patches, gum, and lozenges, helps by reducing withdrawal severity through a safer delivery method than smoking. Varenicline and bupropion are both well-evidenced prescription medications specifically supporting cessation, often outperforming nicotine replacement alone. Combining any of these medications with behavioral counseling produces the best outcomes for most people.
Multiple attempts are the norm rather than the exception; most people who successfully quit do so only after several tries. Each attempt, even an unsuccessful one, can provide useful information about your specific triggers and challenges, which can inform a more effective approach on a subsequent attempt, particularly when combined with effective medication and behavioral support.
Tobacco use disorder is strongly shaped by habitual, repetitive patterns, often tied to specific routines, times of day, or emotional states. These behavioral associations can trigger craving even after the pharmacological withdrawal has eased, which is why having a concrete plan for managing specific high-risk situations, rather than relying solely on general willpower, meaningfully supports more successful, sustained cessation.
Benowitz, N. L. (2010). Nicotine addiction. New England Journal of Medicine, 362(24), 2295–2303. PubMed
Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T. (2016). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, (5), CD006103. PubMed
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews, (5), CD000146. PubMed
Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016). Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews, (3), CD008286. PubMed
Volkow, N. D. (2014). What do we know about the effects of nicotine on health? JAMA, 311(13), 1379–1380. PubMed
